نتایج جستجو برای: کدون v57i aurka

تعداد نتایج: 1108  

Journal: :Science translational medicine 2015
Scott N Furlan Benjamin Watkins Victor Tkachev Ryan Flynn Sarah Cooley Swetha Ramakrishnan Karnail Singh Cindy Giver Kelly Hamby Linda Stempora Aneesah Garrett Jingyang Chen Kayla M Betz Carly G K Ziegler Gregory K Tharp Steven E Bosinger Daniel E L Promislow Jeffrey S Miller Edmund K Waller Bruce R Blazar Leslie S Kean

Graft-versus-host disease (GVHD) is the most common complication of hematopoietic stem cell transplant (HCT). However, our understanding of the molecular pathways that cause this disease remains incomplete, leading to inadequate treatment strategies. To address this, we measured the gene expression profile of nonhuman primate (NHP) T cells during acute GVHD. Utilizing microarray technology, we ...

2015
Ignacio Blanco Karoline Kuchenbaecker Daniel Cuadras Xianshu Wang Daniel Barrowdale Gorka Ruiz de Garibay Pablo Librado Alejandro Sánchez-Gracia Julio Rozas Núria Bonifaci Lesley McGuffog Vernon S. Pankratz Abul Islam Francesca Mateo Antoni Berenguer Anna Petit Isabel Català Joan Brunet Lidia Feliubadaló Eva Tornero Javier Benítez Ana Osorio Teresa Ramón y Cajal Heli Nevanlinna Kristiina Aittomäki Banu K. Arun Amanda E. Toland Beth Y. Karlan Christine Walsh Jenny Lester Mark H. Greene Phuong L. Mai Robert L. Nussbaum Irene L. Andrulis Susan M. Domchek Katherine L. Nathanson Timothy R. Rebbeck Rosa B. Barkardottir Anna Jakubowska Jan Lubinski Katarzyna Durda Katarzyna Jaworska-Bieniek Kathleen Claes Tom Van Maerken Orland Díez Thomas V. Hansen Lars Jønson Anne-Marie Gerdes Bent Ejlertsen Miguel de la Hoya Trinidad Caldés Alison M. Dunning Clare Oliver Elena Fineberg Margaret Cook Susan Peock Emma McCann Alex Murray Chris Jacobs Gabriella Pichert Fiona Lalloo Carol Chu Huw Dorkins Joan Paterson Kai-Ren Ong Manuel R. Teixeira Frans B. L. Hogervorst Annemarie H. van der Hout Caroline Seynaeve Rob B. van der Luijt Marjolijn J. L. Ligtenberg Peter Devilee Juul T. Wijnen Matti A. Rookus Hanne E. J. Meijers-Heijboer Marinus J. Blok Ans M. W. van den Ouweland Cora M. Aalfs Gustavo C. Rodriguez Kelly-Anne A. Phillips Marion Piedmonte Stacy R. Nerenstone Victoria L. Bae-Jump David M. O'Malley Elena S. Ratner Rita K. Schmutzler Barbara Wappenschmidt Kerstin Rhiem Christoph Engel Alfons Meindl Nina Ditsch Norbert Arnold Hansjoerg J. Plendl Dieter Niederacher Christian Sutter Shan Wang-Gohrke Doris Steinemann Sabine Preisler-Adams Karin Kast Raymonda Varon-Mateeva Andrea Gehrig Anders Bojesen Inge Sokilde Pedersen Lone Sunde Uffe Birk Jensen Mads Thomassen Torben A. Kruse Lenka Foretova Paolo Peterlongo Loris Bernard Bernard Peissel Giulietta Scuvera Siranoush Manoukian Paolo Radice Laura Ottini Marco Montagna Simona Agata Christine Maugard Jacques Simard Penny Soucy Andreas Berger Anneliese Fink-Retter Christian F. Singer Christine Rappaport Daphne Geschwantler-Kaulich Muy-Kheng Tea Georg Pfeiler Esther M. John Alex Miron Susan L. Neuhausen Mary Beth Terry Wendy K. Chung Mary B. Daly David E. Goldgar Ramunas Janavicius Cecilia M. Dorfling Elisabeth J. van Rensburg Florentia Fostira Irene Konstantopoulou Judy Garber Andrew K. Godwin Edith Olah Steven A. Narod Gad Rennert Shani Shimon Paluch Yael Laitman Eitan Friedman Annelie Liljegren Johanna Rantala Marie Stenmark-Askmalm Niklas Loman Evgeny N. Imyanitov Ute Hamann Amanda B. Spurdle Sue Healey Jeffrey N. Weitzel Josef Herzog David Margileth Chiara Gorrini Manel Esteller Antonio Gómez Sergi Sayols Enrique Vidal Holger Heyn Dominique Stoppa-Lyonnet Melanie Léoné Laure Barjhoux Marion Fassy-Colcombet Antoine de Pauw Christine Lasset Sandra Fert Ferrer Laurent Castera Pascaline Berthet François Cornelis Yves-Jean Bignon Francesca Damiola Sylvie Mazoyer Olga M. Sinilnikova Christopher A. Maxwell Joseph Vijai Mark Robson Noah Kauff Marina J. Corines Danylko Villano Julie Cunningham Adam Lee Noralane Lindor Conxi Lázaro Douglas F. Easton Kenneth Offit Georgia Chenevix-Trench Fergus J. Couch Antonis C. Antoniou Miguel Angel Pujana

While interplay between BRCA1 and AURKA-RHAMM-TPX2-TUBG1 regulates mammary epithelial polarization, common genetic variation in HMMR (gene product RHAMM) may be associated with risk of breast cancer in BRCA1 mutation carriers. Following on these observations, we further assessed the link between the AURKA-HMMR-TPX2-TUBG1 functional module and risk of breast cancer in BRCA1 or BRCA2 mutation car...

2016
Ying Liu Baocun Sun Tieju Liu Xiulan Zhao Xudong Wang Yanlei Li Jie Meng Qiang Gu Fang Liu Xueyi Dong Peimei Liu Ran Sun Nan Zhao

Tumor cell vasculogenic mimicry (VM), a newly defined pattern of tumor blood supply, signifies the functional plasticity of aggressive cancer cells forming vascular networks. VM and cancer stem cells (CSCs) have been shown to be associated with tumor growth, local invasion, and distant metastasis. In our previous study, CSCs in triple-negative breast cancer were potential to participate in VM f...

Journal: :Oncology reports 2015
Emre Gerçeker Seda Orenay Boyacıoglu Elmas Kasap Ahmed Baykan Hakan Yuceyar Hatice Yıldırım Semin Ayhan Ender Ellidokuz Mehmet Korkmaz

Ulcerative colitis (UC) is an important risk factor for colorectal cancer (CRC). Histone modifications are one of the epigenetic mechanisms that may have key roles in the carcinogenesis of CRC. At present, there are no studies comparing histone modification patterns of UC and CRC in the literature. Therefore the aim of the present study was to investigate whether genes, particularly those invol...

2012
Tewfik Hamidi Carla E Cano Daniel Grasso Maria Noé Garcia Maria José Sandi Ezequiel L Calvo Jean-Charles Dagorn Gwen Lomberk Raul Urrutia Sandro Goruppi Arkaitz Carracedo Guillermo Velasco Juan L Iovanna

Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. In this work we demonstrated that both Nupr1 and HIF1alpha are co-expressed in human PDAC samples and negatively correlate with survival time and therefore could be used as prognosis markers. In addition, we also demonstrated that PDAC cells become resistant to the metabolic stress by activatin...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007
Fergus J Couch Olga Sinilnikova Robert A Vierkant V Shane Pankratz Zachary S Fredericksen Dominique Stoppa-Lyonnet Isabelle Coupier David Hughes Agnès Hardouin Pascaline Berthet Susan Peock Margaret Cook Caroline Baynes Shirley Hodgson Patrick J Morrison Mary E Porteous Anna Jakubowska Jan Lubinski Jacek Gronwald Amanda B Spurdle Rita Schmutzler Beatrix Versmold Christoph Engel Alfons Meindl Christian Sutter Jurgen Horst Dieter Schaefer Kenneth Offit Tomas Kirchhoff Irene L Andrulis Eduard Ilyushik Gordon Glendon Peter Devilee Maaike P G Vreeswijk Hans F A Vasen Ake Borg Katja Backenhorn Jeffery P Struewing Mark H Greene Susan L Neuhausen Timothy R Rebbeck Katherine Nathanson Susan Domchek Theresa Wagner Judy E Garber Csilla Szabo Michal Zikan Lenka Foretova Janet E Olson Thomas A Sellers Noralane Lindor Heli Nevanlinna Johanna Tommiska Kristiina Aittomaki Ute Hamann Muhammad U Rashid Diana Torres Jacques Simard Francine Durocher Frederic Guenard Henry T Lynch Claudine Isaacs Jeffrey Weitzel Olufunmilayo I Olopade Steven Narod Mary B Daly Andrew K Godwin Gail Tomlinson Douglas F Easton Georgia Chenevix-Trench Antonis C Antoniou

The AURKA oncogene is associated with abnormal chromosome segregation and aneuploidy and predisposition to cancer. Amplification of AURKA has been detected at higher frequency in tumors from BRCA1 and BRCA2 mutation carriers than in sporadic breast tumors, suggesting that overexpression of AURKA and inactivation of BRCA1 and BRCA2 cooperate during tumor development and progression. The F31I pol...

2012
Vikas Sehdev DunFa Peng Mohammed Soutto M. Kay Washington Frank Revetta Jeffrey Ecsedy Alexander Zaika Tilman T. Rau Regine Schneider-Stock Abbes Belkhiri Wael El-Rifai

Esophageal adenocarcinomas are poorly responsive to chemotherapeutics. This study aimed to determine the levels of Aurora kinase A (AURKA) and the therapeutic potential ofMLN8237, an investigational AURKA inhibitor, alone and in combination with cisplatin. Using quantitative real-time PCR, we detected frequent AURKA gene amplification (15 of 34, 44%) and mRNA overexpression (37 of 44, 84%) in e...

Journal: :Molecular cancer therapeutics 2012
Vikas Sehdev DunFa Peng Mohammed Soutto M Kay Washington Frank Revetta Jeffrey Ecsedy Alexander Zaika Tilman T Rau Regine Schneider-Stock Abbes Belkhiri Wael El-Rifai

Esophageal adenocarcinomas are poorly responsive to chemotherapeutics. This study aimed to determine the levels of Aurora kinase A (AURKA) and the therapeutic potential of MLN8237, an investigational AURKA inhibitor, alone and in combination with cisplatin. Using quantitative real-time PCR, we detected frequent AURKA gene amplification (15 of 34, 44%) and mRNA overexpression (37 of 44, 84%) in ...

2015
JIA CHEN HUIQI LU WANG ZHOU HUABIN YIN LISHUANG ZHU CHANG LIU PENGFEI ZHANG HUIMIN HU YILI YANG HUANXING HAN

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) have been used to treat non-small cell lung carcinoma (NSCLC) patients that have EGFR-activating mutations. EGFR-TKI monotherapy in most NSCLC patients with EGFR mutations who initially respond to EGFR-TKIs results in the development of acquired resistance. We investigated the role of fibroblasts in stromal cell-medi...

2008
Aimee L. Jackson Mao Mao Sumire Kobayashi Teresa Ward Matthew Biery Hongyue Dai Steven R. Bartz Peter S. Linsley

We identified gene expression signatures predicting responsiveness to a Kinesin-5 (KIF11) inhibitor (Kinesin-5i) in cultured colon tumor cell lines. Genes predicting resistance to Kinesin-5i were enriched for those from chromosome 20q, a region of frequent amplification in a number of tumor types. siRNAs targeting genes in this chromosomal region identified AURKA, TPX2 and MYBL2 as genes whose ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید